Home › Funds › Palo Alto Investors LP › BCYC
Palo Alto Investors LP position in BCYC
BICYCLE THERAPEUTICS PLC · Health Care
Palo Alto Investors LP reported holding 201,890 shares of BCYC (BICYCLE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$856K, representing 0.12% of its reported portfolio and ranking #47 among its reported holdings. Palo Alto Investors LP has disclosed BCYC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's BCYC position evolved
Palo Alto Investors LP first disclosed a stake in BCYC in Q3 2024 at 59,582 shares (US$1.3M). The position peaked in Q4 2024 at 248,934 shares, worth US$3.5M. Across 8 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 201,890 shares valued at US$856K. Notable position changes include a 318% increase in Q4 2024 (shares fell 39% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 59.58K | $1.35M | New |
| Q4 2024 | 248.93K | $3.49M | Add |
| Q1 2025 | 248.93K | $2.11M | Hold |
| Q2 2025 | 248.93K | $1.73M | Hold |
| Q3 2025 | 221.07K | $1.71M | Reduce |
| Q4 2025 | 221.07K | $1.57M | Hold |
| Q1 2026 | 201.89K | $936.77K | Reduce |
| Q2 2026 | 201.89K | $856.01K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCYC and 13F data
BCYC (BICYCLE THERAPEUTICS PLC) is a Health Care company. 11 other funds we track also report a position in BCYC — the largest reported positions include BAKER BROS. ADVISORS LP (US$46.2M), FCPM III SERVICES B.V. (US$14.7M), Long Focus Capital Management, LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCYC
- BAKER BROS. ADVISORS LP 10.89M sh · $46.15M · Q2 2026
- FCPM III SERVICES B.V. 3.47M sh · $14.71M · Q2 2026
- Long Focus Capital Management, LLC 3.31M sh · $14.04M · Q2 2026
- GSK plc 1.53M sh · $6.49M · Q2 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held BCYC?
Palo Alto Investors LP has disclosed BCYC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Palo Alto Investors LP's current position in BCYC?
As of Q2 2026, Palo Alto Investors LP holds 201.89K shares of BCYC (BICYCLE THERAPEUTICS PLC), valued at $856.01K, representing 0.12% of its reported portfolio and ranking #47.
Has Palo Alto Investors LP been buying or selling BCYC?
In the latest 13F filing (Q2 2026), Palo Alto Investors LP held unchanged its position in BCYC. The position peaked in Q4 2024 at 248.93K shares.
Which other funds hold BCYC?
Other major institutional holders of BCYC include BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., Long Focus Capital Management, LLC, among 11 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.